Amneal Pharmaceuticals, Inc. (AMRX) › Gross ProfitAmneal Pharmaceuticals, Inc. (AMRX) — Gross ProfitAnnual figures by period end, from SEC filings.2016-12-31: $597.46M2017-12-31: $526.18M2018-12-31: $716.40M2019-12-31: $353.00M2020-12-31: $628.39M2021-12-31: $768.97M2022-12-31: $784.71M2023-12-31: $820.57M2024-12-31: $1.02B2025-12-31: $1.11B$1.11B2016-12-31Gross Profit (USD)2025-12-31Period endedGross ProfitChange YoYSource filing2025-12-31$1.11B+9.1%2026-02-27From 2025-01-012024-12-31$1.02B+24.4%2026-02-27From 2024-01-012023-12-31$820.57M+4.6%2026-02-27From 2023-01-012022-12-31$784.71M+2.0%2025-02-28From 2022-01-012021-12-31$768.97M+22.4%2024-03-14From 2021-01-012020-12-31$628.39M+78.0%2023-03-03From 2020-01-012019-12-31$353.00M-50.7%2022-03-01From 2019-01-012018-12-31$716.40M+36.2%2021-03-01From 2018-01-012017-12-31$526.18M-11.9%2020-03-02From 2017-01-012016-12-31$597.46M—2019-03-01From 2016-01-01Other metrics: RevenueCost of RevenueOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)